Congratulations to Dr. Chao Zheng, honoured with One To Watch by The Society of Nuclear Medicine and Molecular Imaging 2024
Faculty Awards & Recognition
Dr. Chao Zheng of PharmTox, has been recognized as “one to watch” by The Society of Nuclear Medicine and Molecular Imaging for 2024. This honour recognizes early career professionals with the potential to shape the future of nuclear medicine and molecular imaging across all spectrums of this cutting-edge specialty.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), headquartered in Reston, VA, is a nonprofit scientific and professional organization that promotes the science, technology, and practical application of nuclear medicine and molecular imaging. SNMMI strives to be a leader in unifying, advancing, and optimizing molecular imaging, with an ultimate goal of improving human health. With 15,000 members worldwide, SNMMI represents nuclear and molecular imaging professionals, all of whom are committed to the advancement of the field.
SNMMI’s Ones to Watch campaign is a showcase for rising talent in the field, offering a platform to increase recognition for early career professionals within our specialty. As the field continues to expand, a new wave of talent is at the forefront. This is the 6th year of the SNMMI One’s to Watch program. The concept originated from the Early Career Professionals Committee in 2018 and the first group of One’s to Watch were announced in spring 2019.
